• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Oncology

Increased frailty associated with childhood cancer survivorship

byAndrew Bishara
November 25, 2013
in Oncology, Pediatrics
Reading Time: 3 mins read
Increased frailty associated with childhood cancer survivorship
Share on FacebookShare on Twitter

Image: PD Ewing Sarcoma

1. The prevalence of frailty among young adult childhood cancer survivors (CCS) is similar to that in adults 65 years old and older without cancer history.

2. CCS may face accelerated aging, with increased risk of death and chronic conditions. 

Evidence rating level:  2 (Good)

Study Rundown: Given the many advances in the treatment of childhood cancer over the last few decades, the long-term health risks childhood cancer survivors (CCS) face are becoming increasingly important. Previous studies have found that CCS face chronic health conditions and increased hospitalizations and mortality relative to their peers. Furthermore, many report symptoms that interfere with daily life, suggest premature aging. The purpose of this study was to test whether frailty, an indicator of early aging and a predictor of mortality, would be more prevalent among CCS and whether it can predict subsequent poor health.

The authors found that the prefrailty and frailty phenotypes had very high prevalence among CCS compared to values for peers without cancer history in the literature. Their prevalence among young adult CCS was similar to that among adults 65 years old who had not had childhood cancer (9.6% of women, 5.2% of men). Baseline frailty was also associated with an increased risk of death and of chronic condition onset. Based on these findings, the authors concluded that CCS may experience accelerated aging.

RELATED REPORTS

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

This study benefits from its cohort design and large number of enrollees. However, it should be noted that this was a retrospective study, and prospective assessments earlier in survivorship will be necessary to better elucidate the relationship between frailty and risk for chronic conditions and death. Furthermore, as no matching was done between the CCS and control groups, no direct comparison was done due to concerns of confounding. Volunteer bias regarding the CCS who agreed to participate should also be considered. Nevertheless, this study helps to confirm that CCS may have additional health needs compared to others in their age group, and so present a more complex issue for patient care.

Click to read the article in JCO

Relevant reading: Deficits in physical function among young childhood cancer survivors

In-Depth [retrospective cohort study]: The authors of this study recruited a total of 1922 members of the St. Jude Lifetime cohort, all of whom are at least 10 years from original cancer diagnosis (mean age 33 years old). The comparison group of 341 members was drawn from family and friends of patients being treated at St. Jude Children’s research hospital. The primary outcomes measured were the pre-frailty and frailty phenotypes, which were defined as two and three or greater of the following conditions: low muscle mass, self-reported exhaustion, low energy expenditure, slow walking speed, and weakness. Morbidity was defined as grade 3 to 4 chronic conditions (Common Terminology Criteria).

The prevalence of prefrailty and frailty were 31.5% and 13.1% among women and 12.9 and 2.7% among men. Frail CCS were more likely than non-frail survivors to have a chronic condition (82.1% vs 73.8%). After adjusting for chronic conditions, baseline frailty was associated with risk of death (hazard ratio, 2.6; 95% CI, 1.2-6.2) and chronic condition onset (relative risk 2.2, 95% 1.2 to 4.2).

By Monica Parks and Andrew Bishara

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: frailtymorbiditymortalitypediatric canceryoung adult
Previous Post

Educational intervention increases breastfeeding duration in minorities

Next Post

Consistent parenting linked to lower child BMI

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Home nursing visits for elderly after hospitalization may reduce short term mortality
Chronic Disease

Physical frailty is associated with increased risk of epilepsy

May 20, 2026
Next Post
Gestational weight loss may improve outcomes for obese women

Consistent parenting linked to lower child BMI

Influenza vaccine associated with lower risk of major cardiovascular events

Antivirals linked to reduced mortality among children with influenza

Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

2 Minute Medicine Rewind November 18-24, 2013

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic exposure to particulate matter is associated with increased cardiovascular risk
  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.